Compounds > 1-(3-chlorophenyl)biguanide
Page last updated: 2024-10-21

1-(3-chlorophenyl)biguanide and Irritable Bowel Syndrome

1-(3-chlorophenyl)biguanide has been researched along with Irritable Bowel Syndrome in 2 studies

1-(3-chlorophenyl)biguanide: RN given refers to parent cp; a 5-HT3 receptor agonist

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakata-Fukuda, M1
Hirata, T2
Keto, Y2
Yamano, M2
Yokoyama, T2
Uchiyama, Y1
Sengoku, T1
Seki, N1

Other Studies

2 other studies available for 1-(3-chlorophenyl)biguanide and Irritable Bowel Syndrome

ArticleYear
Inhibitory effect of the selective serotonin 5-HT₃ receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats.
    European journal of pharmacology, 2014, May-15, Volume: 731

    Topics: Animals; Benzimidazoles; Biguanides; Duodenum; Hydrogen-Ion Concentration; Irritable Bowel Syndrome;

2014
Inhibitory effect of ramosetron on corticotropin releasing factor- and soybean oil-induced delays in gastric emptying in rats.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Animals; Antidiarrheals; Benzamides; Benzimidazoles; Benzyl Compounds; Biguanides; Corticotropin-Rel

2012